🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER-1 and HER...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-09-15
Trial ID
NCT05346861
Treatments Being Tested
This study is a single-arm, prospective, open label clinical study for eval...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06-01
Trial ID
NCT03947242
Treatments Being Tested
This is a real world study to evaluate the efficacy and safety of inetetamb...
Status
Unknown
Location
Jiangsu Provincial People's Hospital
Start Date
2020-01-01
Trial ID
NCT05764941
Treatments Being Tested
Trastuzumab resistance, which is a common therapeutic challenge in HER2 pos...
Status
Unknown
Location
Multiple Locations
Start Date
2021-08-01
Trial ID
NCT04963595
Treatments Being Tested
In this phase 2 single-arm clinical trial, 30 patients with HER2-positive m...
Status
Unknown
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2022-02-13
Trial ID
NCT05823623
Treatments Being Tested
Patients with salivary gland carcinoma were divided into groups according t...
Status
Recruiting
Location
Fei Ma
Start Date
2023-08-15
Trial ID
NCT06145308
Treatments Being Tested